On December 17 2019, leaders from business, academia and the government gathered in Tokyo to explore how Japanese partners can help end malaria by 2030. The event was hosted by Malaria No More Japan as part of their ZERO Malaria 2030 Campaign, and it served as the official launch of M2030 in Japan. Dr. Keizo Takemi, member of the Japanese House of Councillors and WHO Goodwill Ambassador for Universal Health Coverage, gave the keynote speech to open the event.
M2030 already counts on three partners from Japan: Sumitomo Chemical, Dentsu, and Sompo Insurance Indonesia. They are three very different companies, but they share a commitment to eliminate malaria in Asia and beyond. Each of these partners contribute in different ways. Sumitomo Chemical supports vector control programs in Asia, and engages on the M2030 Champions Council; Dentsu developed the M2030 branding and has supported public campaigns; and Sompo Insurance is helping M2030 to innovate in its fundraising efforts. With M2030 Japan off the grounds, we expect additional Japanese companies to join the M2030 movement in the near future to help make history and defeat malaria together.